DSI Alyoss is an allograft material, comprised of a combination of cortical and cancellous bone, and presented in a convenient, ready-to-use syringe. It is harvested from sections of the illium and then ground into several particulate sizes, resulting in a unique mix. In this blend the cancellous bone’s porous architecture supplies a scaffold, promoting osteoconduction and accelerating revascularization, while the cortical component provides lamellar structure, possessing density and strength similar to that of the native bone.
DSI Alyoss is a viable alternative to using an autogenous graft from the patient, bringing a number of significant benefits. The need for a second surgery site is eliminated, along with potential complications and infections, post-operative pain, additional anesthesia and a longer healing process.
Complete safety and high quality of the bone are ensured by numerous treatment sequences and exceptional measures. Only EU-registered tissue banks are used as a source, where virtually all the donors undergo stringent screening and extensive tests before being accepted into the banks. After that the bone is processed into DBM (Demineralized Bone Matrix) to expose osteoinductive growth factors in highly innovative facilities under aseptic technique to avoid any possible cross-contamination and meet strict release standards. The last step of the production is gamma sterilization to deliver a clinically effective product, neutral to immune reactions of the host.
Thanks to the unique combination of the cell structure DSI Alyoss bone graft material becomes irreplaceable in sinus lifting procedure. DSI Alyoss can be adjusted more properly in the sinus floor, it is more biocompatible than other bone materials and the healing process is faster and more predictable.
Also, the material comes as a ready-to-use solution in a syringe which makes it more accurate and easier to work with for filling the maxillary sinus during the sinus lift.
DSI Alyoss may be used alone or mixed with an autogenous bone in order to increase the osteoinductive properties of the graft.
- Corticocancellous blend
- Excellent clinical results
- Top quality
- Safe and reliable
- Highly biocompatible
- No immunogenic reaction
- Rapid growth of the new bone
- Convenient handling
- Only qualified donors from EU-registered tissue banks after rigorous screening